🟢 Insulet is trading 9.51% up in after-hours trading

Insulet is trading 9.51% up at $158.85 in after-hours trading, but the catalyst remains unclear.

• Shares closed at $145.06 on August 12, 2026.
• No new earnings release, FDA announcement, product update, or analyst action was identified.
• The August 12 lawsuit alert alleges manufacturing and disclosure issues and is unlikely to explain the gain; the Nasdaq Composite rose 0.55%. Delayed news should be rechecked.